Catalent has unveiled plans to expand integrated turnkey softgel capabilities at its facility in Eberbach, Germany.   The $14 million expansion, which is scheduled to be completed by mid-2020, includes two new softgel encapsulation lines dedicated to Catalent’s proprietary Vegicaps technology. This addition is driven by the increased global demand for animal-free consumer health products, and these new lines will be completed by September 2019. The investment also includes new printing technolog...